# Drug-Drug Interaction Potential of Mavorixafor

> **NCT06914869** · PHASE1 · COMPLETED · sponsor: **X4 Pharmaceuticals** · enrollment: 38 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Mavorixafor
- **DRUG:** Carbamazepine
- **DRUG:** Efavirenz

## Key facts

- **NCT ID:** NCT06914869
- **Lead sponsor:** X4 Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-18
- **Primary completion:** 2025-05-19
- **Final completion:** 2025-05-19
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06914869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06914869, "Drug-Drug Interaction Potential of Mavorixafor". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06914869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*